R N Brogden, R C Heel, T M Speight, G S Avery. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsBenzothiadiazinesBlood Pressure/drug effectsClinical Trials as TopicDiureticsDrug Eruptions/etiologyDrug Therapy, CombinationHeart Rate/drug effectsHumansHydralazine/adverse effectsHydralazine/therapeutic useHypertension/drug therapyHypertension/physiopathologyKidney/drug effectsKidney Diseases/drug therapyKineticsMethyldopa/adverse effectsMethyldopa/therapeutic usePrazosin/adverse effectsPrazosin/metabolismPrazosin/pharmacologyPrazosin/therapeutic useQuinazolines/pharmacologyRenin/bloodSodium Chloride Symporter Inhibitors/therapeutic useTime Factors
Substances: See more » BenzothiadiazinesDiureticsQuinazolinesSodium Chloride Symporter InhibitorsHydralazineMethyldopaReninPrazosin
Year: 1977 PMID: 143363 DOI: 10.2165/00003495-197714030-00002
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546